Cardinal Health Recalls B-Hydroxybutyrate LiquiColor Due to Temperature Abuse
Cardinal Health is recalling B-Hydroxybutyrate LiquiColor test kits because they were stored outside approved temperature ranges, which may lead to patient misdiagnosis.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II, and the source explicitly states that using the products may result in misdiagnosis, which constitutes a risk of harm where injury has not yet been reported.
Plain-English summary
Cardinal Health Inc. is recalling B-Hydroxybutyrate LiquiColor (Item code CH2440058), a product used for the quantitative determination of B-Hydroxybutyrate in human serum or plasma. The recall is limited to Lot 193462.
The recall was initiated because three products requiring refrigerated storage were incorrectly stored outside of approved temperature ranges. The use of these temperature-abused products may result in the misdiagnosis of a patient.
The affected products were distributed nationwide in North Carolina, Kansas, and Alabama. Consumers and healthcare providers should stop using the affected lot and contact Cardinal Health for further instructions.
The recalled product
- Product
- B-Hydroxybutyrate LiquiColor, Item code CH2440058 - Product Usage: Product is used for the quantitative determination of B-Hydroxybutyrate in human serum or plasma.
- Manufacturer
- Cardinal Health Inc.
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot 193462
Distribution
Part of a larger recall action
This product is one of 3 recalled by Cardinal Health Inc. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Cardinal Health Inc.
See all →- HighEnoxaparin syringe bags recalled after being labeled with the wrong strength
FDA (Drugs) · 2025-09-03
- ModerateXolair auto-injectors exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateRecombinate antihemophilic factor vials exposed to temperatures outside labeled storage
FDA (Drugs) · 2025-08-13
- ModerateXolair 75 mg syringes exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateWegovy injection recalled due to temperature exposure during shipping
FDA (Drugs) · 2025-05-07
Same hazard · misdiagnosis
See all →- SevereBeckman Coulter MicroScan Panel Update DVD Kits Recalled
FDA (Devices) · 2026-08-12
- HighBlood Analysis System Software Error Can Assign Wrong Patient Name
FDA (Devices) · 2025-01-01
- HighBlood Analysis System Recalled Due to Patient Name Assignment Software Error
FDA (Devices) · 2025-01-01
- HighPhilips Vue PACS Diagnostic Viewer Software Recall for Calculation Errors
FDA (Devices) · 2024-11-27
- HighChange Healthcare Cardiology Hemo Software Recalled for Calculation Errors
FDA (Devices) · 2024-10-23